Alvotech Holdings S.A Logo

Alvotech Holdings S.A

ALVO | LU

Overview

Corporate Details

ISIN(s):
LU2458332611
LEI:
222100DCZBOWV5DZ8372
Country:
Luxembourg
Address:
9, RUE DE BITBOURG, L-1273 LUXEMBOURG
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alvotech is a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines. The company's mission is to improve lives by increasing patient access to high-quality, affordable biologic treatments worldwide. Alvotech operates a vertically integrated platform, managing the entire process from cell line development to fill-and-finish manufacturing. This end-to-end approach provides control, scale, and speed in its development and production processes. For global commercialization, the company forms strategic partnerships with third parties to market and distribute its robust pipeline of biosimilars to patients.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Alvotech Holdings S.A. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-21 10:30
Regulatory News Service
Alvotech hlýtur leyfi til markaðssetningar í Evrópu á hliðstæðu við augnlyfið E…
Icelandic 7.4 KB
2025-08-21 10:30
Regulatory News Service
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar …
English 17.6 KB
2025-08-13 22:15
Earnings Release
Alvotech birtir uppgjör fyrir fyrstu sex mánuði ársins og kynnir nýjustu áfanga…
Icelandic 41.2 KB
2025-08-13 22:15
Earnings Release
Alvotech Reports Results for the First Six Months of 2025 and Provides a Busine…
English 48.1 KB
2025-08-06 14:00
Report Publication Announcement
Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. kl. 12 á …
Icelandic 3.8 KB
2025-08-06 14:00
Report Publication Announcement
Alvotech Announces Webcast to Report Financial Results for the First Half of 20…
English 6.0 KB
2025-07-28 23:35
Report Publication Announcement
Skjöl lögð inn til Verðbréfaeftirlits Bandaríkjanna (SEC)
Icelandic 775 bytes
2025-07-28 23:35
Foreign Filer Report
Information filed with the U.S. Securities and Exchange Commission
English 785 bytes
2025-07-10 10:40
Board/Management Information
Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs
Icelandic 6.9 KB
2025-07-10 10:40
Board/Management Information
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
English 12.7 KB
2025-07-09 10:30
M&A Activity
Alvotech kaupir alla starfsemi Ivers-Lee Grou
Icelandic 6.5 KB
2025-07-09 10:30
M&A Activity
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of…
English 12.7 KB
2025-07-04 01:02
Transaction in Own Shares
Notification for the purposes of article 13 of the Luxembourg law of 11 January…
English 1.2 KB
2025-07-02 12:23
Director's Dealing
Notification_Managers Transaction_Richard Davies
English 84.6 KB
2025-07-02 12:21
Director's Dealing
Notification_Managers Transaction_Hjörleifur Pálsson
English 85.0 KB

Automate Your Workflow. Get a real-time feed of all Alvotech Holdings S.A filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alvotech Holdings S.A via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK